The global Rabies Vaccination market size was valued at US$ 1237 million in 2024 and is forecast to a readjusted size of USD 1644 million by 2031 with a CAGR of 4.2% during review period.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Rabies Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rabies Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rabies Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rabies Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rabies Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabies Vaccination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabies Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Rabies Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
麻豆原创 segment by Application
Pre-exposure
Post-exposure
Major players covered
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rabies Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Vaccination, with price, sales quantity, revenue, and global market share of Rabies Vaccination from 2020 to 2025.
Chapter 3, the Rabies Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Rabies Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Vaccination.
Chapter 14 and 15, to describe Rabies Vaccination sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Rabies Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Vero Cell
1.3.3 BHK
1.3.4 Chick Embryo Cell
1.3.5 Human Diploid Cells
1.3.6 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Rabies Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pre-exposure
1.4.3 Post-exposure
1.5 Global Rabies Vaccination 麻豆原创 Size & Forecast
1.5.1 Global Rabies Vaccination Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Rabies Vaccination Sales Quantity (2020-2031)
1.5.3 Global Rabies Vaccination Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Rabies Vaccination Product and Services
2.1.4 Bharat Biotech Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Bavarian Nordic
2.2.1 Bavarian Nordic Details
2.2.2 Bavarian Nordic Major Business
2.2.3 Bavarian Nordic Rabies Vaccination Product and Services
2.2.4 Bavarian Nordic Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Bavarian Nordic Recent Developments/Updates
2.3 Sanofi-Pasteur
2.3.1 Sanofi-Pasteur Details
2.3.2 Sanofi-Pasteur Major Business
2.3.3 Sanofi-Pasteur Rabies Vaccination Product and Services
2.3.4 Sanofi-Pasteur Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Sanofi-Pasteur Recent Developments/Updates
2.4 Chengda Bio
2.4.1 Chengda Bio Details
2.4.2 Chengda Bio Major Business
2.4.3 Chengda Bio Rabies Vaccination Product and Services
2.4.4 Chengda Bio Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Chengda Bio Recent Developments/Updates
2.5 KANGH
2.5.1 KANGH Details
2.5.2 KANGH Major Business
2.5.3 KANGH Rabies Vaccination Product and Services
2.5.4 KANGH Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 KANGH Recent Developments/Updates
2.6 Prcmise
2.6.1 Prcmise Details
2.6.2 Prcmise Major Business
2.6.3 Prcmise Rabies Vaccination Product and Services
2.6.4 Prcmise Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Prcmise Recent Developments/Updates
2.7 Henan Grand Biopharma
2.7.1 Henan Grand Biopharma Details
2.7.2 Henan Grand Biopharma Major Business
2.7.3 Henan Grand Biopharma Rabies Vaccination Product and Services
2.7.4 Henan Grand Biopharma Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Henan Grand Biopharma Recent Developments/Updates
2.8 Zhuoyi Biological
2.8.1 Zhuoyi Biological Details
2.8.2 Zhuoyi Biological Major Business
2.8.3 Zhuoyi Biological Rabies Vaccination Product and Services
2.8.4 Zhuoyi Biological Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Zhuoyi Biological Recent Developments/Updates
2.9 ZhongKe Biopharm
2.9.1 ZhongKe Biopharm Details
2.9.2 ZhongKe Biopharm Major Business
2.9.3 ZhongKe Biopharm Rabies Vaccination Product and Services
2.9.4 ZhongKe Biopharm Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 ZhongKe Biopharm Recent Developments/Updates
2.10 Ningbo Rongan Biological
2.10.1 Ningbo Rongan Biological Details
2.10.2 Ningbo Rongan Biological Major Business
2.10.3 Ningbo Rongan Biological Rabies Vaccination Product and Services
2.10.4 Ningbo Rongan Biological Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Ningbo Rongan Biological Recent Developments/Updates
2.11 Indian Immunologicals
2.11.1 Indian Immunologicals Details
2.11.2 Indian Immunologicals Major Business
2.11.3 Indian Immunologicals Rabies Vaccination Product and Services
2.11.4 Indian Immunologicals Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Indian Immunologicals Recent Developments/Updates
3 Competitive Environment: Rabies Vaccination by Manufacturer
3.1 Global Rabies Vaccination Sales Quantity by Manufacturer (2020-2025)
3.2 Global Rabies Vaccination Revenue by Manufacturer (2020-2025)
3.3 Global Rabies Vaccination Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Rabies Vaccination by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Rabies Vaccination Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Rabies Vaccination Manufacturer 麻豆原创 Share in 2024
3.5 Rabies Vaccination 麻豆原创: Overall Company Footprint Analysis
3.5.1 Rabies Vaccination 麻豆原创: Region Footprint
3.5.2 Rabies Vaccination 麻豆原创: Company Product Type Footprint
3.5.3 Rabies Vaccination 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rabies Vaccination 麻豆原创 Size by Region
4.1.1 Global Rabies Vaccination Sales Quantity by Region (2020-2031)
4.1.2 Global Rabies Vaccination Consumption Value by Region (2020-2031)
4.1.3 Global Rabies Vaccination Average Price by Region (2020-2031)
4.2 North America Rabies Vaccination Consumption Value (2020-2031)
4.3 Europe Rabies Vaccination Consumption Value (2020-2031)
4.4 Asia-Pacific Rabies Vaccination Consumption Value (2020-2031)
4.5 South America Rabies Vaccination Consumption Value (2020-2031)
4.6 Middle East & Africa Rabies Vaccination Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Rabies Vaccination Sales Quantity by Type (2020-2031)
5.2 Global Rabies Vaccination Consumption Value by Type (2020-2031)
5.3 Global Rabies Vaccination Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Rabies Vaccination Sales Quantity by Application (2020-2031)
6.2 Global Rabies Vaccination Consumption Value by Application (2020-2031)
6.3 Global Rabies Vaccination Average Price by Application (2020-2031)
7 North America
7.1 North America Rabies Vaccination Sales Quantity by Type (2020-2031)
7.2 North America Rabies Vaccination Sales Quantity by Application (2020-2031)
7.3 North America Rabies Vaccination 麻豆原创 Size by Country
7.3.1 North America Rabies Vaccination Sales Quantity by Country (2020-2031)
7.3.2 North America Rabies Vaccination Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Rabies Vaccination Sales Quantity by Type (2020-2031)
8.2 Europe Rabies Vaccination Sales Quantity by Application (2020-2031)
8.3 Europe Rabies Vaccination 麻豆原创 Size by Country
8.3.1 Europe Rabies Vaccination Sales Quantity by Country (2020-2031)
8.3.2 Europe Rabies Vaccination Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Rabies Vaccination Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Rabies Vaccination Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Rabies Vaccination 麻豆原创 Size by Region
9.3.1 Asia-Pacific Rabies Vaccination Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Rabies Vaccination Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Rabies Vaccination Sales Quantity by Type (2020-2031)
10.2 South America Rabies Vaccination Sales Quantity by Application (2020-2031)
10.3 South America Rabies Vaccination 麻豆原创 Size by Country
10.3.1 South America Rabies Vaccination Sales Quantity by Country (2020-2031)
10.3.2 South America Rabies Vaccination Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Rabies Vaccination Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Rabies Vaccination Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Rabies Vaccination 麻豆原创 Size by Country
11.3.1 Middle East & Africa Rabies Vaccination Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Rabies Vaccination Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Rabies Vaccination 麻豆原创 Drivers
12.2 Rabies Vaccination 麻豆原创 Restraints
12.3 Rabies Vaccination Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Rabies Vaccination and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Vaccination
13.3 Rabies Vaccination Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Vaccination Typical Distributors
14.3 Rabies Vaccination Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
听
听
*If Applicable.
